NEW YORK (GenomeWeb) – Enzo Biochem today announced that the New York State Department of Health has granted conditional approval for the firm's FlowScript assay to detect mRNA from human papilloma virus (HPV) oncogenes E6 and E7.

Enzo Clinical Labs may now offer the flow cytometry-based assay to clients. The HPV assay allows for simultaneous analysis of multiple genes expressed in a single cell, the firm said in a statement, and is the first assay available for the FlowScript platform. The firm added that relevant reagents will be marketed through its Life Sciences division.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.